🇺🇸 FDA
Patent

US 9718881

Anti-Activin A antibodies and uses thereof

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 9718881 (Anti-Activin A antibodies and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Aug 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
44
CPC classes
A61K, A61K2039/505, A61K2039/507, A61K39/395, A61K39/3955